Insights from 2023 ESMO Annual Meeting
ESMO 2023 Summary: "The CLEVER Trial - Targeting Disseminated Dormant Tumor Cells With Hydroxychloroquine, Everolimus, or the Combination to Prevent Recurrent BC"
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Angela DeMichele
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Angela DeMichele
Login to view comments.
Click here to Login
Breast